XJPX4921
Market cap0kUSD
Dec 17, Last price
2,790.00JPY
1D
0.00%
1Q
-0.36%
Jan 2017
241.49%
Name
Fancl Corp
Chart & Performance
Profile
Fancl Corporation engages in the manufacture and sale of cosmetics and dietary supplements. The company provides cosmetics, quasi-drugs, nutritional supplements, and other products in Japan and internationally. It also offers germinated brown rice and kale juice products; develops and distributes undergarments and fashion goods; and distributes cosmetics and nutritional supplements. In addition, the company operates as an insurance agency. It sells its products through online and catalogue, direct store, and wholesale channels. The company was founded in 1980 and is headquartered in Yokohama, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 110,881,000 7.03% | 103,595,000 -0.38% | 103,992,000 -9.50% | |||||||
Cost of revenue | 70,264,000 | 67,662,000 | 66,424,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 40,617,000 | 35,933,000 | 37,568,000 | |||||||
NOPBT Margin | 36.63% | 34.69% | 36.13% | |||||||
Operating Taxes | 3,980,000 | 3,244,000 | 2,153,000 | |||||||
Tax Rate | 9.80% | 9.03% | 5.73% | |||||||
NOPAT | 36,637,000 | 32,689,000 | 35,415,000 | |||||||
Net income | 8,833,000 77.73% | 4,970,000 -33.03% | 7,421,000 -7.42% | |||||||
Dividends | (4,113,000) | (4,109,000) | (4,097,000) | |||||||
Dividend yield | 1.69% | 1.39% | 1.24% | |||||||
Proceeds from repurchase of equity | (1,000) | |||||||||
BB yield | 0.00% | |||||||||
Debt | ||||||||||
Debt current | 10,117,000 | 116,000 | 50,000 | |||||||
Long-term debt | 219,000 | 10,436,000 | 10,220,000 | |||||||
Deferred revenue | (376,000) | (1,055,000) | ||||||||
Other long-term liabilities | 1,877,000 | 2,006,000 | 1,540,000 | |||||||
Net debt | (33,023,000) | (28,028,000) | (21,140,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 11,323,000 | 12,952,000 | 13,097,000 | |||||||
CAPEX | (1,620,000) | (2,025,000) | (5,088,000) | |||||||
Cash from investing activities | (2,201,000) | (1,867,000) | (4,673,000) | |||||||
Cash from financing activities | (4,249,000) | (4,247,000) | (4,155,000) | |||||||
FCF | 33,874,000 | 37,644,000 | 37,730,000 | |||||||
Balance | ||||||||||
Cash | 42,080,000 | 37,039,000 | 30,108,000 | |||||||
Long term investments | 1,279,000 | 1,541,000 | 1,302,000 | |||||||
Excess cash | 37,814,950 | 33,400,250 | 26,210,400 | |||||||
Stockholders' equity | 87,740,000 | 158,079,000 | 155,634,000 | |||||||
Invested Capital | 54,761,050 | 52,273,750 | 57,261,600 | |||||||
ROIC | 68.46% | 59.69% | 60.88% | |||||||
ROCE | 43.87% | 41.76% | 44.44% | |||||||
EV | ||||||||||
Common stock shares outstanding | 121,393 | 121,387 | 121,162 | |||||||
Price | 2,003.00 -17.67% | 2,433.00 -11.01% | 2,734.00 -26.80% | |||||||
Market cap | 243,149,622 -17.67% | 295,334,895 -10.84% | 331,256,749 -26.78% | |||||||
EV | 210,126,622 | 342,434,895 | 383,677,749 | |||||||
EBITDA | 44,649,000 | 40,310,000 | 42,131,000 | |||||||
EV/EBITDA | 4.71 | 8.50 | 9.11 | |||||||
Interest | 51,000 | |||||||||
Interest/NOPBT | 0.14% |